On September 1, 2009 the U.S. Food and Drug Administration (FDA) announced that label warnings for interferon alpha products were updated to reflect some newly recognized safety issues, namely stroke, retinal detachment, peripheral neuropathy, and pulmonary hypertension. Pegylated interferon alpha (Pegasys or PegIntron) is standard treatment for hepatitis C, and pegylated or conventional interferon are used for hepatitis B.
Posts You May Be Interested In
I have stage 4 cirrhosis. I have a good team of drs and will eventually need a transplant. But it is the side effects that are so problematic. Itchy skin, exhaustion, nausea. Slowly I have learned how to overcome each of those with diet, rest, skin care, etc. Really trying to keep a positive attitude. However I spent the weekend in ER with severe pain on my right side. After verifying no clots,...
Hi,My cirrhosis journey started 4 months ago. I went to the ER with abdominal and feet swelling. During testing they discovered I had a blood clot in the portal vein to the liver and said the liver appeared to be cirrhosis. I am 38, never drank, smoked, did drugs, no auto immune disorders, all the hep test come back negative. All the blood work is normal. The most recent blood work, my doctor...